An affiliate of HIG Capital, a global alternative investment firm with $70bn in capital under management, has completed the sale of EYSA Group to Tikehau Investment Management SAS, a global alternative asset manager.
Chicago Atlantic, a private markets investment firm focused on emerging industries, healthcare, and special situations, has named Robert Beasley as Partner and Head of Restructuring, strengthening its operational value-creation capabilities across its portfolio.
European mid-market private equity firm Inflexion has agreed to sell its investment in European LifeCare Group, a vaccinations provider in Europe, to a European private equity group.
Cerberus Capital Management has completed the sale of Electrical Components International to Rosebank Industries in a transaction valued at approximately $1.9bn.
British Columbia Investment Management Corp (BCI) has named Ken Bennett as a strategic adviser for its private equity program, with immediate effect, with a focus on enhancing long-term value creation across BCI Private Equity’s global portfolio.
Asian healthcare-focused private equity firm Quadria Capital is exploring the sale of its minority stake in Indian topical pharmaceuticals company Encube Ethicals, according to a report by Bloomberg citing unnamed sources familiar with the matter.
STORIES OF TRANSFORMATION | With a history dating back centuries, the perfume industry has undergone plenty of change. Yet, one element remains steady: profitability. According to Mordor Intelligence, the market will cross $112bn by 2030, growing at nearly 8% CAGR. Among the many verticals, one niche is cosmetic perfumery glass
Rainier Partners-backed Wilmar has acquired EZRED, a designer, manufacturer, and distributor of lighting, tool organisation, and hand tools for the automotive aftermarket.
Hospitality-focused private investment firm Noble Investment Group, has hired Marc Dober as Senior Director of Asset Management, to focus on driving asset performance, operational efficiencies, revenue growth, and long-term value creation across the firm’s portfolio.
India’s Aurobindo Pharma has emerged as the frontrunner to acquire Prague-based generics manufacturer Zentiva from Advent International in a deal valued at up to $5.5bn, in what would be one of the largest European healthcare exits of the year, according to a report by the Economic Times.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
